Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2022 Apr 20;10(4):e001580corr1. doi: 10.1136/jitc-2020-001580corr1

Correction: Immunotherapy for sarcomas: new frontiers and unveiled opportunities

PMCID: PMC9021803  PMID: 35444062

Birdi HK, Jirovec A, Cortés-Kaplan S, et al. Immunotherapy for sarcomas: new frontiers and unveiled opportunities. J Immunother Cancer 2021;9:e001580. doi:10.1136/jitc-2020-001580.

This article has been corrected since it was first published. The overall response rate for the trial by Kelly et al (reference 97) was cited incorrectly and has now been corrected to 35% (7/20).


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES